4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-009116
EVP, R&D & Chief Scientific Of sold 13,975 shares at $38.55 ($538,736)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Haqq Christopher EVP, R&D & Chief Scientific Of | 2019-02-11 | Sale | −13,975 | $38.55 | $538,736 | 272,718 | D |
| Open-market sales · 13,975 sh · avg $38.55 · $538,736 | |||||||
Loading xslF345X03/doc4.xml…